
Peptides et Protéines
3143 produits trouvés pour "Peptides et Protéines"
D-Ala-(19)-Semaglutide
D-Ala(19)-Semaglutide is a semaglutide impurity. The amino acid at position 19 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Phe(6)-Semaglutide
D-Phe(6)-Semaglutide is a semaglutide impurity. The amino acid at position 6 has been replaced by the D-form of the amino acid D-phenylalanine (D-Phe). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 29 (β-Asp-9)
Beta-Asp-(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the beta-aspartic acid (also known as isoaspartic, isoAsp, β-Asp or beta-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Thr(5)-Semaglutide
D-Thr(5)-Semaglutide is a semaglutide impurity. The amino acid at position 5 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Ser(11)-Semaglutide
D-Ser(11)-Semaglutide is a semaglutide impurity. The amino acid at position 11 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 51 (D-Thr 7)
D-Thr(7)-Semaglutide is a semaglutide impurity. The amino acid at position 7 has been replaced by the D-form of the amino acid D-threonine (D-Thr). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol(R)-3-Methyl-1-(pyrazine- 2-carboxamido)butylboronic acid
The compound is a drug product, analytical, and research material. The molecule has been synthesized and purified by the company's chemists. It is not an API impurity but an impurity standard for HPLC. This compound is a synthetic chemical that does not occur naturally in any living organism. It has been developed for use in drug development and research. The compound was custom synthesized by the company's chemists to meet customer demand for high purity standards of this compound. It is used as a pharmacopoeia standard for HPLC analysis and drug development.Degré de pureté :Min. 95%Semaglutide Impurity 59
D-Arg(28)-Semaglutide is a semaglutide impurity. The amino acid at position 28 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.
Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 60 (D-Arg 30)
D-Arg(30)-Semaglutide is a semaglutide impurity. The amino acid at position 30 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol(S,E)-N-(1-(3-Methylbut-1-enylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
CAS :R-N-(1-(3-methylbut-1-enyl)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide is a drug product that is used for the treatment of bacterial infections. The compound is an impurity in the synthesis of other compounds and is also used as an analytical standard. It is synthesized from commercially available starting materials and through custom synthesis. R-N-(1-(3-methylbut-1-enyl)-1--oxo--3--phenylpropan--2--yl)pyrazine--2--carboxamide has been shown to be metabolized by CYP450 enzymes, which are responsible for the metabolism of many drugs. R-(1-(3Methylbut 1Enylamino)-1Oxo 3Phenylpropan 2Yl)Pyrazine 2Carboxamide has not been evaluated as a drug product and therefore does notFormule :C19H22N4O2Degré de pureté :Min. 95%Masse moléculaire :338.4 g/molD-Ser-(12)-Semaglutide
D-Ser(12)-Semaglutide is a semaglutide impurity. The amino acid at position 12 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 56 (D-Glu 21)
D-Glu(21)-Semaglutide is a semaglutide impurity. The amino acid at position 21 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molLisinopril
CAS :Lisinopril, an ACE inhibitor, treats hypertension, heart failure, heart attacks, and prevents diabetes-related eye and kidney issues.Formule :C21H31N3O5Degré de pureté :97.59% - 99.34%Couleur et forme :SolidMasse moléculaire :405.49(2,6-Dimethylphenoxy)acetic Acid
CAS :Produit contrôléFormule :C10H12O3Couleur et forme :NeatMasse moléculaire :180.24-(Phenylamino)-1-benzyl-4-piperidinecarboxamide
CAS :Produit contrôléApplications Used as modulators of muscarinic receptors for treatment of CNS disorders.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Coghlan, M., et al.: J. Med. Chem., 44, 1627 (2001), Ashcroft, F., et al.: J. Clin. Invest., 115, 2047 (2005), Bryan, J., et al.: Curr. Pharm. Des., 11, 2699 (2005),Formule :C19H23N3OCouleur et forme :NeatMasse moléculaire :309.41N2-(S)-1-Carboxy-3-phenylpropyl-L-lysine
CAS :Produit contrôléStability Hygroscopic
Applications Lisinopryl impurity.
References Goa, K.L., et al.: Drugs, 52, 564 (1996), Cao, X.J., et al.: J. Pharm. Biomed. Anal., 39, 39 (2005),Formule :C16H24N2O4Couleur et forme :White To Light BeigeMasse moléculaire :308.37(S)-(-)-α-Methylbenzylamine
CAS :Produit contrôléApplications (S)-(-)-α-Methylbenzylamine (cas# 2627-86-3) is a compound useful in organic synthesis.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the packageFormule :C8H11NCouleur et forme :NeatMasse moléculaire :121.18Semaglutide impurity
CAS :Lipid chain (stearic bi-acid) plus γ-glutamic acid or glutamate (γ-Glu) amino acid.Formule :C35H63N3O13Masse moléculaire :733.89 g/molCP5V
CAS :CP5V, a PROTAC, degrades Cdc20, halts mitosis, and inhibits cancer growth by targeting it for VHL-mediated ubiquitination and proteasome destruction.Formule :C46H66Cl3N9O12SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1075.49Lysipressin amide, acetate
CAS :Lysipressin amide, acetate is an analog of vasopressin, a powerful vasopressin used to regulate blood pressure. Endogenous vasopressin in most mammalian species.Formule :C48H68N12O15S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1117.26Lysipressin Acetic Acid Salt
CAS :Applications Lysipressin Acetic Acid Salt, is an analog of Vasopressin (A769550), a powerful vasopressor used to modulate blood pressure. An endogenous antidiuretic hormone in most mammalian species. It is released into the blood from nerve terminals in the posterior pituitary and median eminence. It is a neurotransmitter in the central nervous system and also implicated in a variety of physiological processes such as regulating water balance by antidiuretic action.
References Yamashita, K. et al.: Mol. Phylo., 67, 520 (2013); Hua F. et al.: J. Emerg. Med., 44, 434 (2013); Perucca, J. et al.: J. AM. Soc. Nephrol., 19, 1721 (2008); Toba, K. et al.: Prog. Brain Res., 119, 337 (1998); Berrada, K. et al.: J. Biol. Chem., 275, 27229 (2000);Formule :C46H65N13O12S2·xC2H4O2Couleur et forme :White SolidMasse moléculaire :1116.3(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-Alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
CAS :Produit contrôléImpurity Lopinavir EP Impurity R
Applications (αS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide (Lopinavir EP Impurity R) is an impurity of Lopinavir (L469480), a selective HIV protease inhibitor.
References Chitturi, S.R., et al.: J. Pharma. Biomed. Anal., 48, 1430 (2008); Devi, A.S.L., et al.: Magnet. Reson. Chem., 45, 424 (2007);Formule :C47H58N4O7Couleur et forme :NeatMasse moléculaire :791.0Trofinetide (>90%)
CAS :Produit contrôléApplications Trofinetide is a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), that has shown to be neuroprotective in animal models of brain injury.
References Wei, H.H. et al.: J Neuroinflammation. 2009 Aug 5;6:19.Formule :C13H21N3O6Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :315.32Cyclosporin AM 4N
CAS :Produit contrôléFormule :C61H109N11O12Couleur et forme :NeatMasse moléculaire :1188.585-Oxo-L-proline-d5
CAS :Produit contrôléApplications 5-Oxo-L-proline-d5 is a labelled cyclized derivative of L-Glutamic Acid (G596960). The pyroglutamate core has potential application for synthesis of novel anti-bacterials.
References Mischo A. et al.: ChemBioChem., 13, 1421 (2012); Angelov P. et al.: Org. Biomol. Chem.: 10, 3472 (2012);Formule :C5D5H2NO3Couleur et forme :White To Off-WhiteMasse moléculaire :134.14Daptomycin Impurity B1-I
Applications Daptomycin Impurity B1-1 is an impurity of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formule :C44H66N10O15•(C2HF3O2)Couleur et forme :Off White SolidMasse moléculaire :975.0511402N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib
CAS :Produit contrôléApplications N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formule :C19H22N4O3Couleur et forme :White To Off-WhiteMasse moléculaire :354.403(S)-Lisinopril-d5 Sodium
CAS :Produit contrôléFormule :C21H26D5N3NaO5Couleur et forme :NeatMasse moléculaire :433.511-Nitrosopyrrolidine-2-carboxylic Acid
CAS :Produit contrôléApplications 1-nitrosopyrrolidine-2-carboxylic acid (cas# 2571-28-0) is a useful research chemical.
Formule :C5H8N2O3Couleur et forme :NeatMasse moléculaire :144.129(alphaR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt
CAS :Produit contrôléApplications Bortezomib (B675700) intermediate. A boronic acid dipeptide derivative as proteasome inhibitors.
References Kisselev, A., et al.: Chem. Biol., 8, 739 (2001), Kisselev, A., et al.: J. Biol. Chem., 278, 35869 (2003), Verdoes, M., et al.: Chem. Biol., 13, 1217 (2006),Formule :C15H28BNO2·C2HF3O2Couleur et forme :NeatMasse moléculaire :379.229-(2,5-d|-Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin
CAS :Produit contrôléApplications 9-(2,5-d|Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin is a stereoisomer of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formule :C72H99N17O25Couleur et forme :NeatMasse moléculaire :1602.66(D-His2)-Leuprolide Trifluoroacetic Acid Salt
CAS :Produit contrôléImpurity Leuprolide Acetate EP Impurity B TFA salt
Applications Synthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal).
References Vilchez-Martinez, J.A., et al.: Biochem. Biophys. Res. Commun., 59, 1226 (1974), Sennello, L.T., et al.: J. Pharm. Sci., et al.: 75, 158 (1986), Wheeler, J.M., et al.: Am.J. Obstet. Gynecol., 167, 1367 (1992), Eri, L.M., et al.: J. Urol., 150, 359 (1993),Formule :C59H84N16O12·x(C2HF3O2)Couleur et forme :NeatMasse moléculaire :1209.398Boceprevir-d9
CAS :Produit contrôléApplications A labelled NS3 serine protease inhibitor of hepatitis C virus. It is a COVID19-related research product.
References Malcolm, B., et al.: Antimicrob. Agents Chemother., 50, 1013 (2006); Cubero, M., et al.: Virology, 370, 237 (2008); Venkatraman, S., et al.: J. Med. Chem., 49, 6074 (2006);Formule :C272H9H36N5O5Couleur et forme :NeatMasse moléculaire :528.73(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride
CAS :Produit contrôléApplications (αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride is a Bortezomib (B675700) intermediate which is used in the evaluation of bone-targeted proteasome inhibitors for myeloma.
References Agyin, J.K., et al.: Bioorg. Med. Chem. Lett., 23, 6455 (2013); Traenckner, E., et al.: EMBO. J., 13, 5433 (1994)Formule :C24H37BN2O3·ClHCouleur et forme :NeatMasse moléculaire :448.83413,5,3',5'-Tetraiodo Thyroacetamide
CAS :Produit contrôléImpurity Levothyroxine Acetamide Impurity
Applications 3,5,3',5'-Tetraiodo Thyroacetamide is a thyroid hormone analogue, a Thyroxine (T425600) impurity.
References Andre, M., et al.: J. Chromatogr., 741, 146 (1996),Formule :C14H9I4NO3Couleur et forme :Light Orange Colour To Light BrownMasse moléculaire :746.84(S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS :Produit contrôléApplications (S,S)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formule :C19H24N4O4Couleur et forme :NeatMasse moléculaire :372.42(R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium Chloride
CAS :Produit contrôléStability Hygroscopic
Applications (R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium chloride is an important co-factor of mammalian mitochondrial energy metabolism. It is also a good active ingredient for dry-skin.
References Geier, David A., et al.: Neurochem. Res., 38(11), 2336-2341 (2013);Tanno, Osamu, et al.: Fragrance J., 33(8), 82-85 (2005);Formule :C7H16NO3·ClCouleur et forme :White To Off-WhiteMasse moléculaire :197.66(S)-4-Oxo-homophenylalanine Hydrochloride
CAS :Produit contrôléStability Hygroscopic
Applications (S)-4-Oxo-homophenylalanine Hydrochloride is a derivative of L-Homophenylalanine (H600500); an antitumor agent.
References Brunner, Henri., et al.: Eur. J. Med. Chem., 25, 35 (1990)Formule :C10H12ClNO3Couleur et forme :NeatMasse moléculaire :229.66(S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid
CAS :Produit contrôléApplications (S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid is an intermediate for Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);Formule :C31H42N4O6Couleur et forme :NeatMasse moléculaire :566.69(S,S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS :Produit contrôléImpurity Bortezomib USP Impurity L
Stability Unstable in Methanol
Applications (R)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);Formule :C19H24N4O4Couleur et forme :White To Off-WhiteMasse moléculaire :372.42Dodecyl Polyoxyethylene (23) Aldehyde
CAS :Produit contrôléApplications Polyoxyethylene (23) Lauric Acid is an intermediate in the synthesis of Bril L-23 Proline (LIFETC1), a polyethylene glycol derivative of Proline (P755995), an amino acid and precursor (with vitamin C) for collagen, the building block of the structure of tendons, ligaments, arteries, veins and muscles.
References Bondarenko, L.B., et al.: Int. J. Peptides., 2, 1687 (2012); Rimer, T., et al.: Biomacromolecules, 13, 2110 (2012);Formule :C14H28O2(C2H4O)nCouleur et forme :NeatMasse moléculaire :272.42N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS :Produit contrôléApplications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.
References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)Formule :C31H41N3O7Couleur et forme :NeatMasse moléculaire :567.67Deschloro-4’-chloro Clomiphene Hydrochloride
CAS :Produit contrôléApplications An impurity of Clomiphene (C587025).
Formule :C26H29Cl2NOCouleur et forme :NeatMasse moléculaire :442.42(2S)-1-Nitrosopyrrolidine-2-carboxamide
CAS :Produit contrôléFormule :C5H9N3O2Couleur et forme :NeatMasse moléculaire :143.14Linear Daptomycin Hydrochloride Salt
CAS :Applications Linear Daptomycin Hydrochloride Salt is the hydrochloride salt of L466470, which is the open-conformation of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial. Daptomycin Impurity
References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),Formule :C72H103N17O27·x(ClH)Degré de pureté :~80%Couleur et forme :NeatMasse moléculaire :1675.1t-Butyl 4-Bromobutanoate
CAS :Produit contrôléApplications t-Butyl 4-bromobutanoate is a useful research chemical for organic synthesis and other chemical and pharmaceutical processes.
References Brudeli, B., et al.: Bioorg. Med. Chem., 18, 8600 (2010); Colak, S., et al.: Macromolecules, 41, 8436 (2008)Formule :C8H15BrO2Couleur et forme :NeatMasse moléculaire :223.113,5,3',5'-Tetraiodo Thyroaldehyde
CAS :Produit contrôléImpurity Levothyroxine EP Impurity I; T4-Aldehyde (USP)
Applications 3,5,3',5'-Tetraiodo Thyroaldehyde (Levothyroxine EP Impurity I; T4-Aldehyde (USP)) is a Thyroid hormone analogue and a Thyroxine (T425600) analogue.
References Horst, C., et al.: Biochem. J., 261, 945 (1989), Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992), Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999), Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002),Formule :C13H6I4O3Couleur et forme :Light Beige To BrownMasse moléculaire :717.8(S)-Hydroxy Des(boric Acid) Bortezomib
CAS :Produit contrôléImpurity Bortezomib USP Impurity J
Applications (S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl, C. et al.: Chem. and Eng. News, 87, 41 (2009)Formule :C19H24N4O3Couleur et forme :NeatMasse moléculaire :356.42N-[(1S)-2-[(3-Methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
CAS :Produit contrôléFormule :C19H24N4O2Couleur et forme :White To Off-WhiteMasse moléculaire :340.4195(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS :(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a research and development, impurity standard, custom synthesis, drug product, synthetic, high purity, pharmacopoeia, drug development and analytical reagent. CAS No. 162148-17-6Formule :C9H12N2O4SDegré de pureté :Min. 95%Masse moléculaire :244.27 g/mol


